Treatment typically involves vitamin B12 supplementation, either through oral supplements or injections, depending on the severity of the deficiency and underlying causes.
In this review, we discuss briefly the present understanding of TNF--mediated biology and the current injectable therapies in clinical use, and focus on some of the new therapeutic approaches with oral, small-molecule inhibitors
Key outcomes from the 84-week study: Mean weight loss: CagriSema 23% Tirzepatide 25.5% Treatment-regimen estimand (all randomized patients): CagriSema 20.2% Tirzepatide 23.6% While CagriSema demonstrated clinically meaningful weight reduction, it fell short of the predefined statistical threshold for non-inferiority
Endogenously, this occurs 612 times per day, with the largest pulses during slow-wave sleep
What it does in the MicroInfuser context: dermal hydration (low-MW), volumetric plumping in upper dermis (mid-MW), barrier-protective film in the post-procedure window (high-MW), and CD44 receptor engagement on fibroblasts